KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

There are many mechanisms at work here, but the blood sugar increase is probably secondary to the weight gain, rather than ...

But here’s a little insider info: Ozempic’s just the show name. The real star? Semaglutide, the active ingredient doing all ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The intricate landscape of medical research continues to unveil groundbreaking approaches to managing chronic joint health ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why diabetes and weight loss drugs work better than alcohol medications.

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...